<DOC>
	<DOCNO>NCT01213836</DOCNO>
	<brief_summary>This phase IV 20 -32 day prospective , double blind , double-dummy , randomise crossover study evaluate effect quetiapine XR quetiapine IR cognitive performance patient schizophrenia stabilize single antipsychotic medication .</brief_summary>
	<brief_title>Compare Effect Cognitive Functioning Two Formulations Seroquel , Seroquel XR IR Patients With Stable Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Provision write informed consent prior study specific procedure Documented clinical diagnosis schizophrenia , paranoid type , least 2 year randomisation meeting Diagnostic Statistical Manual Mental Disorders , 4th Edition ( DSMIV , American Psychiatric Association 2000 ) criterion schizophrenia ( DSMIV cod 295.3 ) confirm MINI version 5.0 Outpatient status enrolment Dose quetiapine IR quetiapine XR unchanged last 56 day randomisation Diagnosis DSMIV Axis I disorder include inclusion criterion within 6 month randomisation ( e.g. , alcohol dependence psychoactive substance dependence full remission , concurrent organic mental disorder , mental retardation [ axis II diagnosis ] ) degree may interfere patient 's ability cooperate . Previous stable use high dosage benzodiazepine one year Significant neurological medical history ( complicate head trauma judge investigator , epilepsy , meningoencephalitis ) Use follow medication : antipsychotic drug quetiapine within 28 day prior randomisation depot antipsychotic injection within two dose interval ( depot ) randomisation ( Visit 2 ) psychoactive drug within 14 day prior randomisation ( hypnotic anxiolytic drug , allow ) Use concomitant therapy likely affect cognition , Medication prohibit 28 day prior randomisation : benzodiazepine , amphetamine , reboxitin , atomoxinetine , buspiron , donepezil , duloxetine , galantamine , ginko biloba , memantine , methylphenidate , modafinil , rivastigmine , tacrine , smoke cessation therapy varencicline dosage form nicotine replacement therapy . Medication prohibit 14 day prior randomisation : irreversible monoamine oxidase inhibitor ( MAOI ) , tricyclic antidepressant ( TCA ) , biperiden , antoicholinergic agent ( even indication extra pyramidal symptom urinary symptom )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Stable schizophrenia</keyword>
	<keyword>cognitive functioning</keyword>
</DOC>